CATALYST CLINICAL RESEARCH EUROPE, LTD.
BLOCK 11, SUITE 2, 2ND FLOOR, ALDERLEY PARK, MACCLESFIELD  SK10 4TG- Active
- Private Limited Company
- Company No. 08872035
- Last Updated: 01 Mar 2024
Company Profile
CATALYST CLINICAL RESEARCH EUROPE, LTD. was incorporated on Friday, January 31, 2014 as a Private Limited Company with registered address in MACCLESFIELD. CATALYST CLINICAL RESEARCH EUROPE, LTD. has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 11 years and 24 days.
Name | CATALYST CLINICAL RESEARCH EUROPE, LTD. |
---|---|
Company number | 08872035 |
Company type | Private Limited Company |
Incorporation date | 31 Jan 2014 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
BLOCK 11, SUITE 2, 2ND FLOOR ALDERLEY PARK MACCLESFIELD SK10 4TG |
---|---|
Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Project Constellation Holdings, Inc. Independence Blvd, Suite 100, 28412 |
Dates: Friday, April 29, 2022 - Monday, September 12, 2022
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Catalyst Clinical Research, Llc Independence Blvd, Suite 100, 28412 |
Dates: Friday, April 29, 2022 - Thursday, September 22, 2022
ownership of shares 75 to 100 percent
voting rights 50 to 75 percent
significant influence or control as firm
|
Mr Stephen Mcconchie Nationality: British |
Dates: Wednesday, April 6, 2016 - Friday, April 29, 2022
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Mr Jonathan Lewis Nationality: British |
Dates: Wednesday, April 6, 2016 - Friday, April 29, 2022
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Accounts and Confirmation
Type of accounts | SMALL |
---|---|
End of financial Year | 31 December |
Next annual accounts due | 30 September 2024, (-147 days left) |
Latest accounts | 31 December 2022 |
Next confirmation statement due | 24 February 2017 |
Last confirmation statement dated | 27 January 2016 |
Mortgages
Total of Mortgages | 4 |
---|---|
Mortgages Outstanding | 2 |
Mortgages Partially Satisfied | 0 |
Mortgages Satisfied/Paid | 2 |
Previous Names
Name | Change Date |
---|---|
CATALYST CLINICAL RESEARCH EUROPE, LTD. | 31 Jan 2014 |
APTUS CLINICAL LIMITED | 27 Apr 2023 |